New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

PBPHvsGDOCETF Comparison

ETF 1
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
+0.48%
VS
ETF 2
GDOC

Goldman Sachs Future Health Care Equity ETF

This fund is part of
Healthcare Technology
+0.38%

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. Goldman Sachs Future Health Care Equity ETF (GDOC) is part of the Healthcare Technology segment. Both ETFs have the same top 1 sector exposures: Healthcare. PBPH is less expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.75% for GDOC. PBPH is up 10.08% year-to-date (YTD) with +$968M in YTD flows. GDOC performs worse with 1.89% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of PBPH and GDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PBPH vs GDOC performance and flow charts

Performance

-2.00.02.04.06.0%Aug 11Aug 18Aug 25Sep 1Sep 8

Cumulative Flows

010,000,00020,000,00030,000,00040,000,000Aug 11Aug 18Aug 25Sep 1Sep 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/11/2026
1M3MYTD1Y3Y5Y
Perf.
PBPH
GDOC
-0.72%-2.76%
+7.13%+7.68%
+10.08%+1.89%
n/a+10.63%
n/a+14.18%
n/an/a
Flows
PBPH
GDOC
+$35M-
+$139M-$3M
+$968M-$2M
--$3M
--$86M
--
Volatility and drawdown
3M1Y3Y5Y
Volatility
PBPH
GDOC
+20.50%+15.32%
n/a+15.27%
n/a+14.96%
n/an/a
Max drawdown
PBPH
GDOC
-6.59%-6.08%
n/a-15.39%
n/a-22.18%
n/an/a
Max drawdown duration
PBPH
GDOC
17d23d
n/a221d
n/a449d
n/an/a
Trading data

Create an account to view trading data

Join for free
PBPH
GDOC
Last sale
9/11/2026 at 1:30 PM
$27.80
$36.32
Previous close
09/10/2026
$27.85
$36.35
Consolidated volume
09/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

GDOC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PBPH
GDOC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
PBPH
GDOC
Last price
$27.80
$36.32
1D performance
-0.15%
-0.08%
AuM$1.01 B$19.06 M
E/R0.13%0.75%
Characteristics
PBPH
GDOC
Management strategyPassiveActive
ProviderTidalGoldman Sachs
BenchmarkBITA Global Pharma and Biotech Select Index-
N° of holdings5238
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 24, 2025November 11, 2021
ESGNoNo
Advertisement
Exposure

Countries

PBPH
USA
65.24%
Switzerland
10.52%
United Kingdom
7.15%
Other
17.09%
GDOC
USA
79.52%
Other
20.48%

Sectors

PBPH
Healthcare
99.46%
Other
0.54%
GDOC
Healthcare
97.92%
Other
2.08%
Advertisement

Diversification

PBPH

Total weight of top 15 holdings out of 15

75.4%
GDOC

Total weight of top 15 holdings out of 15

71.18%

Top 15 holdings

Data as of July 31, 2026
PBPH
Eli Lilly & Co.
15.14%
Johnson & Johnson
9.55%
AbbVie, Inc.
7.06%
Merck & Co., Inc.
4.97%
Roche Holding AG
4.70%
Amgen, Inc.
4.62%
Novartis AG
4.45%
AstraZeneca PLC
3.88%
Gilead Sciences, Inc.
3.77%
Novo Nordisk A/S
3.75%
Pfizer Inc.
3.28%
Bristol Myers Squibb Co.
3.06%
Vertex Pharmaceuticals, Inc.
2.82%
GSK Plc
2.24%
Sanofi
2.10%
GDOC
Eli Lilly & Co.
13.11%
Johnson & Johnson
8.63%
Merck & Co., Inc.
6.83%
UnitedHealth Group, Inc.
6.44%
Guardant Health, Inc.
4.41%
argenx SE
3.71%
AstraZeneca PLC
3.59%
Edwards Lifesciences Corp.
3.30%
Thermo Fisher Scientific, Inc.
3.30%
Agilent Technologies, Inc.
3.28%
DexCom, Inc.
3.23%
Apogee Therapeutics, Inc.
3.00%
Intuitive Surgical, Inc.
2.88%
Lonza Group AG
2.79%
Cencora, Inc.
2.67%
Frequently asked questions about PBPH and GDOC

How have the PBPH and GDOC ETFs performed in 2026?

As of September 11, 2026, PBPH is up 10.08% year-to-date (YTD), while GDOC has returned 1.89%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PBPH or GDOC?

Year-to-date, the PBPH ETF saw +$968M in flows, compared to -$2M for GDOC.

Which ETF is bigger: PBPH or GDOC?

As of September 11, 2026, PBPH holds $1.01 B in assets under management (AUM), while GDOC manages $19.06 M.

What sectors do the PBPH and GDOC ETFs invest in?

PBPH leans toward sectors like Healthcare. Meanwhile, GDOC focuses on Healthcare.

What are the top holdings of the PBPH ETF and GDOC ETF?

PBPH top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. GDOC holds in its top three: Eli Lilly & Co., Johnson & Johnson and Merck & Co., Inc..

Which ETF is more diversified: PBPH or GDOC?

PBPH holds 53 securities with 75.4% of its assets in the top 15. GDOC has 38 securities and a top 15 weight of 71.18%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder